A researcher discovers mid-study that a placebo control group is being harmed by withholding a newly proven effective treatment. What is the ethically required action?
-
A
Continue the study to preserve statistical power
-
B
Stop the trial and offer the effective treatment to all participants
-
C
Inform only the IRB but continue enrollment
-
D
Reduce the placebo group size but continue